Your search history is turned on.
Date: February 29, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Exhibit 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Stephen P. Carey, certify that: 1. I have reviewed this Annual Report on Form 10-K of ANI Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necess...
Exhibit 31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Nikhil Lalwani, certify that: 1. I have reviewed this Annual Report on Form 10-K of ANI Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessar...
Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations Please read the following discussion in conjunction with Item 1A. (Risk Factors) and our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K. Some of the statements in the following discussion are forward-looking statements. See t...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______. Commission fi...
Date: February 29, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F3A CLASS 3A REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, CAREY, Stephen P., an officer of the reporting issuer noted below have examined this Form 13- 502F3A (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonable diligence...
Create participation fee form FORM 13-501F4 CLASS 3A REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, CAREY, Stephen P., an officer of the reporting issuer noted below have examined this Form 13-501F4 (the Form) being submitted hereunder to the Alberta Securities Commission and certify that to my knowl edge, having exercised reasonable diligence, ...
Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders of ANI Pharmaceuticals, Inc. Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of ANI Pharmaceuticals, Inc. and Subsidiaries (the Company) as of December 31, 202...
Date: November 8, 2023 Jurisdictions: Alberta, British Columbia, Ontario
ANIP-2023.09.30-10Q-EX-31.1 Exhibit 31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Nikhil Lalwani, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of ANI Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a mat...
ANIP-2023.09.30-10Q-EX-31.2 Exhibit 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Stephen P. Carey, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of ANI Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a m...
ANIP-2023.09.30-10Q Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations The following Managements Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the unaudited interim condensed consolidated financial statements and the accompanying notes thereto included in Part I...